European allergen extract units and potency: review of available information
- 29 February 2008
- journal article
- review article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 100 (2), 137-145
- https://doi.org/10.1016/s1081-1206(10)60422-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsAnnals of Allergy, Asthma & Immunology, 2006
- Safety and tolerability of grass pollen tablets in sublingual immunotherapy – a phase‐1 studyAllergy, 2006
- Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitisAnnals of Allergy, Asthma & Immunology, 2004
- The create project: EU support for the improvement of allergen standardization in EuropeAllergy, 2004
- Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled studyAllergy, 2004
- Efficacy and safety of sublingual immunotherapy with high dose house dust mite extract in asthmatic children - a multicenter randomized double-blind, and placebo-controlled study*1Journal of Allergy and Clinical Immunology, 2004
- Sublingual immunotherapy for allergic rhinitisPublished by Wiley ,2003
- Biologic activity of Dermatophagoides siboney and Blomia tropicalis allergens in exposed and unexposed mite‐allergic individuals. Effect of patient selection on the biologic standardization of mite extractsAllergy, 1999
- Comparison of skin‐prick test assay and reverse enzyme immunoassay competition (REINA‐C) for biological activity of allergensClinical and Experimental Allergy, 1994
- The major allergen content of allergenic preparations reflects their biological activityAllergy, 1992